| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 329.255 | 275.870 | 264.084 | 276.230 | 274.494 | 222.708 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 332.024 | 275.941 | 264.088 | 278.370 | 274.810 | 385.580 | 0 | 0 | 269 | 0 |
| Total Expenses - EUR | 332.156 | 289.999 | 270.298 | 274.894 | 261.450 | 222.139 | 681 | 18 | 0 | 0 |
| Gross Profit/Loss - EUR | -133 | -14.057 | -6.210 | 3.477 | 13.360 | 163.440 | -680 | -18 | 269 | 0 |
| Net Profit/Loss - EUR | -133 | -14.057 | -6.661 | 3.477 | 11.478 | 139.757 | -680 | -18 | 228 | 0 |
| Employees | 9 | 8 | 7 | 7 | 5 | 2 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmacia Algevita S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.646 | 28.182 | 26.432 | 24.813 | 23.296 | 364 | 319 | 302 | 301 | 299 |
| Current Assets | 85.845 | 69.740 | 74.092 | 75.912 | 67.988 | 143.956 | 26.301 | 26.383 | 26.572 | 26.423 |
| Inventories | 53.947 | 45.843 | 50.871 | 51.942 | 54.930 | 19.824 | 19.399 | 19.459 | 19.422 | 19.313 |
| Receivables | 17.788 | 6.417 | 17.652 | 19.822 | 11.719 | 113.995 | 2.993 | 3.002 | 3.291 | 3.273 |
| Cash | 5.903 | 17.480 | 5.568 | 4.148 | 1.339 | 10.137 | 3.910 | 3.922 | 3.859 | 3.838 |
| Shareholders Funds | -15.394 | -29.295 | -25.674 | -21.726 | -9.827 | 130.158 | 18.233 | 18.271 | 18.443 | 18.340 |
| Social Capital | 90 | 89 | 9.938 | 9.756 | 9.567 | 9.427 | 9.218 | 9.247 | 9.219 | 9.167 |
| Debts | 130.886 | 127.217 | 126.198 | 122.451 | 101.111 | 14.251 | 8.429 | 8.455 | 8.470 | 8.423 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Algevita S.r.l.